GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

The TGA urged doctors to warn Ozempic users to 'be careful' and check the dose before administering it. Earlier this month, official data revealed more than 100 deaths in the United Kingdom had now ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...

Competition is expected to ramp up next year when cheaper alternative versions of semaglutide — the active ingredient in Novo’s Wegovy — launch after semaglutide’s China patent expires. Their ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

Serious concerns have emerged about falsified weight loss medicines circulating in the UK market, posing significant health risks to Britons. GP Dr Bhavini Shah warned that undeclared ingredients in ...